Oncolytics Biotech Inc T.ONC

Over 4M options to the board...

[Lesalpes29]

It’s probably more than enough to make them rich IF a buyout in billions is signed. Let’s go, all longs are behind you! GL

[Capitalista]

I count only 420,000 options issued this month.  It's dilution, but not as bad as 4 million.

[Lesalpes29]

Total of their options when you add 420k yesterday's options. Don't know the average costs of them. GL

[fox7mf]

It is more than enough to make them all very wealthy when a B/O in the billions is announced. Yes, it certainly feels like it's a question of 'when' not 'if.' It's hard to get much more extremely positive news than ONC has gotten in 2022. The positive results are certain to continue with regards to Bracelet. PFE already know these results, and are going to be somewhat

[Davepark5]

How can you keep spouting this nonsense??? 10 billion?  but we cant even budge 10 cents on all this news???   the market isnt stupid....it sees what we are seeing....why does the volume and stock price continue to stink?   you are completely delusional Fox....patty hearst and the symbionese liberation army stuff here

[Kswdelux]

Timing is the big question now... With mBC simmering on the back burner with PFE's 90 day exclusivity... with nothing or little more to report on mBC until late Q1 or early Q2 2023, MHO the next news to expect is... BREAK THROUGH DESIGNATION for Panc. 3x the current standard of care for Panc... I think it is warranted!  I think that has to be the next milestone. And based on the

[westcoast1000]

ksw, If I understand it correctly Breathrough would allow us (or rather Roche) to sell the combo of pela, tecentriq, and the two chemo drugs that were used in the last trial on a trial basis. Then they monitor the patients using it in a "phase 4" trial. If the results show no increased risk and continued efficacy then they would get the actual license. I would think that would be an

[westcoast1000]

Wrong!  I have muddled up fast track, breakthrough and accelerated approval again. 

[jimsenior]

@ westcoast. Search FDA Breakthrough Status versus Accelerated Approval. I think we want the latter but am going to read again.

[jimsenior]

@ westcoast. I looked up FDA Accelerated Approval, and I cannot see why GOBLET does not advance to AA and Phase 4. Perhaps ONC is waiting for more info to seal the deal. My guess Phase 4  - GOBLET.

[westcoast1000]

Thanks for the update, jim. I think they would have to apply, (or Roche and ONCY would apply to be preciese), because their drug would be involved. Then they wait for the FDA to decide whether to give it to them. But a lot of people would probably like to take it tomorrow to get a tripling of time left with panc cancer.  Moreover, the Tecentriq and chemo combo is already approved, IIRC. So

[jimsenior]

Yes. One tends to focus on pela, and forget we have company. Given the GOBLET results, I suppose one could say Roche and Oncolytics are inextricably joined. Same probably applies to Merck/PFE and Oncolytics.  Not sure how this unfolds, but it will be interesting. Many avenues. Cheers.

[jimsenior]

Ongoing/Cancer Accelerated Approvals  -  (AA) As of 12/13/2022 there were 67 Trials I cannot be absolutely certain, but I did not see any pancreatic cancer trials in the above noted group.

[Lesalpes29]

Many thanks. Still dreaming for an epic run for the SP. Probably coming faster than we think. GL

[itntdf]

https://pancan.org/news/another-fda-treatment-approval-underscores-promise-of-precision-medicine/

[Kswdelux]

  LOL... looks like I messed that up as well... Looks like we want Accelarated or better yet Priority Either will solidify ONC/ONCY and SP will jump. Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Fast Track   A process designed to